Cargando…
Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus
PURPOSE: To investigate risk factors for the development and progression of diabetic retinopathy (DR) and long‐term visual outcomes in Dutch patients with type 1 diabetes mellitus (T1DM). METHODS: Cumulative incidences were calculated for DR, vision‐threatening DR (VTDR), defined as (pre)proliferati...
Autores principales: | Schreur, Vivian, van Asten, Freekje, Ng, Heijan, Weeda, Jack, Groenewoud, Joannes M.M., Tack, Cees J., Hoyng, Carel B., de Jong, Eiko K., Klaver, Caroline C.W., Jeroen Klevering, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174939/ https://www.ncbi.nlm.nih.gov/pubmed/30188024 http://dx.doi.org/10.1111/aos.13815 |
Ejemplares similares
-
Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema
por: Schreur, Vivian, et al.
Publicado: (2018) -
Long‐term outcomes of vitrectomy for proliferative diabetic retinopathy
por: Schreur, Vivian, et al.
Publicado: (2020) -
RETINAL HYPERREFLECTIVE FOCI IN TYPE 1 DIABETES MELLITUS
por: Schreur, Vivian, et al.
Publicado: (2020) -
The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective
por: van Asten, Freekje, et al.
Publicado: (2018) -
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2016)